<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Moderna Archives - Claims Journal</title>
	<atom:link href="https://www.claimsjournal.com/topics/moderna/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.claimsjournal.com/topics/moderna/</link>
	<description>Insurance news and resources for the claims industry</description>
	<lastBuildDate>Wed, 04 Mar 2026 16:12:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://www.claimsjournal.com/app/uploads/2015/12/cropped-claimsjournal-32x32.png</url>
	<title>Moderna Archives - Claims Journal</title>
	<link>https://www.claimsjournal.com/topics/moderna/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Moderna to Pay About $1 Billion to Settle Arbutus Litigation</title>
		<link>https://www.claimsjournal.com/news/national/2026/03/05/336067.htm</link>
		
						<dc:creator><![CDATA[Admin]]></dc:creator>
						<pubDate>Thu, 05 Mar 2026 06:00:16 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[COVID]]></category>
		<category><![CDATA[damages]]></category>
		<category><![CDATA[lawsuit]]></category>
		<category><![CDATA[liability]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=336067</guid>

							<description><![CDATA[Moderna Inc. agreed to pay $950 million to settle litigation related to the delivery technology behind its Covid shot, removing a looming financial risk for the struggling vaccine maker. The company has settled all litigation worldwide with Arbutus Biopharma Corp. &#8230;]]></description>
				
		
		<enclosure url="https://www.claimsjournal.com/app/uploads/2026/03/Moderna-researcher-Bloomberg-580x387.jpg" length="71193" type="image/jpeg" />	</item>
		<item>
		<title>Moderna Will Pay up to $2.25 Billion to Settle COVID Vaccine Patent Dispute</title>
		<link>https://www.claimsjournal.com/news/national/2026/03/03/336058.htm</link>
		
						<dc:creator><![CDATA[Admin]]></dc:creator>
						<pubDate>Wed, 04 Mar 2026 01:18:31 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[COVID]]></category>
		<category><![CDATA[damages]]></category>
		<category><![CDATA[lawsuit]]></category>
		<category><![CDATA[liability]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=336058</guid>

							<description><![CDATA[Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to settle a long-running legal fight over the technology that made its COVID-19 vaccine possible, the companies said on Tuesday. Under &#8230;]]></description>
				
		
			</item>
		<item>
		<title>BioNTech Sues Moderna for Patent Infringement Over COVID Shots</title>
		<link>https://www.claimsjournal.com/news/national/2026/02/20/335806.htm</link>
		
						<dc:creator><![CDATA[Admin]]></dc:creator>
						<pubDate>Fri, 20 Feb 2026 06:00:17 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[BioNTech]]></category>
		<category><![CDATA[COVID]]></category>
		<category><![CDATA[lawsuit]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=335806</guid>

							<description><![CDATA[German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna&#8217;s COVID-19 vaccine mNEXSPIKE infringes a patent related to BioNTech and Pfizer&#8217;s competing shot Comirnaty. The lawsuit said that mNEXSPIKE, Moderna&#8217;s next-generation COVID shot approved by &#8230;]]></description>
				
		
			</item>
		<item>
		<title>Pfizer, BioNTech Ask UK Court to Overturn Moderna&#8217;s COVID Vaccine Patent Win</title>
		<link>https://www.claimsjournal.com/news/national/2025/07/10/331691.htm</link>
		
						<dc:creator><![CDATA[Admin]]></dc:creator>
						<pubDate>Thu, 10 Jul 2025 13:09:39 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[COVID-19 vaccine]]></category>
		<category><![CDATA[lawsuit]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[Pfizer]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=331691</guid>

							<description><![CDATA[Pfizer and its German partner BioNTech asked London&#8217;s Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna&#8217;s patents, in the latest round of a long-running legal dispute between the two sides. A &#8230;]]></description>
				
		
			</item>
		<item>
		<title>GlaxoSmithKline Sues Moderna for US Patent Infringement Over COVID Vaccines</title>
		<link>https://www.claimsjournal.com/news/national/2024/10/16/326837.htm</link>
		
						<dc:creator><![CDATA[Admin]]></dc:creator>
						<pubDate>Wed, 16 Oct 2024 05:00:00 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[damages]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[lawsuit]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[patent infringement]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=326837</guid>

							<description><![CDATA[British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating GSK&#8217;s patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax. According to the two lawsuits, Moderna&#8217;s lipid &#8230;]]></description>
				
		
			</item>
		<item>
		<title>Pfizer Vs. Moderna COVID Vaccine Patents Battle Heading to Appeal</title>
		<link>https://www.claimsjournal.com/news/national/2024/09/26/326491.htm</link>
		
						<dc:creator><![CDATA[Admin]]></dc:creator>
						<pubDate>Thu, 26 Sep 2024 05:00:01 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[COVID]]></category>
		<category><![CDATA[lawsuit]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[Pfizer]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=326491</guid>

							<description><![CDATA[Pfizer and Moderna&#8217;s legal battle over their rival COVID-19 vaccines will continue after London&#8217;s High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and its German partner BioNTech sued Moderna in London &#8230;]]></description>
				
		
			</item>
		<item>
		<title>Viewpoint: Who&#8217;s on the Hook if Vaccines Go Wrong?</title>
		<link>https://www.claimsjournal.com/news/national/2021/01/07/301359.htm</link>
		
						<dc:creator><![CDATA[Jim Sams]]></dc:creator>
						<pubDate>Thu, 07 Jan 2021 18:16:11 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Covid-19]]></category>
		<category><![CDATA[indemnity]]></category>
		<category><![CDATA[inoculations]]></category>
		<category><![CDATA[liability shield]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[World Health Organization]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=301359</guid>

							<description><![CDATA[The Covid-19 vaccines are here and distribution has begun. But what if something goes wrong? Whether it&#8217;s a loss of income, hefty medical bills or other serious adverse effects from getting a shot, someone has to pick up the tab, &#8230;]]></description>
				
		
			</item>
		<item>
		<title>Vaccine Injury Claims Could Face Bureaucratic &#8216;Black Hole&#8217;</title>
		<link>https://www.claimsjournal.com/news/national/2020/12/23/301167.htm</link>
		
						<dc:creator><![CDATA[Admin]]></dc:creator>
						<pubDate>Wed, 23 Dec 2020 16:40:20 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[coronavirus]]></category>
		<category><![CDATA[Countermeasures Injury Compensation Program]]></category>
		<category><![CDATA[distribution]]></category>
		<category><![CDATA[H1N1 swine flu vaccine]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[willful misconduct]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=301167</guid>

							<description><![CDATA[Lost in the U.S. launch of the coronavirus vaccine is a fact most don&#8217;t know when they roll up their sleeves: In rare cases of serious illness from the shots, the injured are blocked from suing and steered instead to &#8230;]]></description>
				
		
		<enclosure url="https://www.claimsjournal.com/app/uploads/2020/12/AP_COVID-19.vaccine-580x387.jpg" length="36652" type="image/jpeg" />	</item>
		<item>
		<title>Vaccine Carrots or Sticks? Businesses Grapple With Getting Employees Inoculated</title>
		<link>https://www.claimsjournal.com/news/national/2020/12/11/300978.htm</link>
		
						<dc:creator><![CDATA[Admin]]></dc:creator>
						<pubDate>Fri, 11 Dec 2020 18:03:58 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[employment law]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Pew Research poll]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[workplace programs]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=300978</guid>

							<description><![CDATA[HOUSTON &#8212; U.S. workers could soon face choices such as free COVID-19 shots and a cash bonus if all get immunized, or those unwilling to be vaccinated get reassigned or even lose their jobs. Those options are being studied by &#8230;]]></description>
				
		
			</item>
	</channel>
</rss>
